JP2018526419A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018526419A5 JP2018526419A5 JP2018512955A JP2018512955A JP2018526419A5 JP 2018526419 A5 JP2018526419 A5 JP 2018526419A5 JP 2018512955 A JP2018512955 A JP 2018512955A JP 2018512955 A JP2018512955 A JP 2018512955A JP 2018526419 A5 JP2018526419 A5 JP 2018526419A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- alkyl
- hydrogen
- aryl
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CCC1C(*)CC2OC(CC(*)(CC3)*C3(*)/C=C3)C3N(C(CN(*)C3)C(*)C3NS(C3CC=CCC*(*)CC(C)(*)CC3)(=O)=O)C2CC(C)(*)C1 Chemical compound CCC1C(*)CC2OC(CC(*)(CC3)*C3(*)/C=C3)C3N(C(CN(*)C3)C(*)C3NS(C3CC=CCC*(*)CC(C)(*)CC3)(=O)=O)C2CC(C)(*)C1 0.000 description 4
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562216172P | 2015-09-09 | 2015-09-09 | |
| US62/216,172 | 2015-09-09 | ||
| PCT/US2016/050688 WO2017044569A1 (en) | 2015-09-09 | 2016-09-08 | Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018526419A JP2018526419A (ja) | 2018-09-13 |
| JP2018526419A5 true JP2018526419A5 (cg-RX-API-DMAC7.html) | 2019-10-17 |
| JP6955485B2 JP6955485B2 (ja) | 2021-10-27 |
Family
ID=56936551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018512955A Expired - Fee Related JP6955485B2 (ja) | 2015-09-09 | 2016-09-08 | 抗がん剤としての複素環式の限定された三環系スルホンアミド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10759790B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3347355B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6955485B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN108349961B (cg-RX-API-DMAC7.html) |
| AR (1) | AR105975A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2997784A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW201808930A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017044569A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017512766A (ja) | 2014-03-11 | 2017-05-25 | アイカーン スクール オブ メディスン アット マウント サイナイＩｃａｈｎ Ｓｃｈｏｏｌ ｏｆ Ｍｅｄｉｃｉｎｅ ａｔ Ｍｔ． Ｓｉｎａｉ | 抗癌剤としてのトリシクリル−２−アミノシクロアルカノール由来スルホンアミド |
| CN106458916A (zh) | 2014-03-11 | 2017-02-22 | 西奈山伊坎医学院 | 受限制的三环磺酰胺 |
| CA2994830A1 (en) * | 2015-08-06 | 2017-02-09 | Icahn School Of Medicine At Mount Sinai | Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols |
| EP3347350A1 (en) | 2015-09-09 | 2018-07-18 | Icahn School of Medicine at Mount Sinai | Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents |
| WO2021150700A1 (en) * | 2020-01-22 | 2021-07-29 | Icahn School Of Medicine At Mount Sinai | N-substituted-3-tricyclyl piperidine derivatives as anticancer and neuroprotective agents |
| WO2021150697A1 (en) * | 2020-01-22 | 2021-07-29 | Icahn School Of Medicine At Mount Sinai | N-substituted-3-tricyclyl piperidine derivatives as anticancer and neuroprotective agents |
| CN112778257A (zh) * | 2021-01-21 | 2021-05-11 | 香港科技大学 | 一种将糠醇氧化为二氢吡喃酮类衍生物的绿色方法 |
| KR20230145089A (ko) * | 2021-02-08 | 2023-10-17 | 랍타 테라퓨틱스 오와이 | 단백질 포스파타제 2a(pp2a)의 치환된 사이클릭 조절인자 및 이를 사용하는 방법 |
| EP4543863A1 (en) * | 2022-06-23 | 2025-04-30 | University Of Ottawa | Ferroptosis inhibitors and uses thereof |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634766A (en) | 1983-10-31 | 1987-01-06 | Merck Frosst Canada, Inc. | 1,4-diaza-phenothiazines |
| GB8510680D0 (en) | 1985-04-26 | 1985-06-05 | Smith Kline French Lab | Pyridine derivatives |
| US4882351A (en) | 1987-10-14 | 1989-11-21 | Roussel Uclaf | Tricyclic compounds |
| DE69431470T2 (de) | 1993-07-26 | 2003-08-14 | Eisai Co., Ltd. | Sulfonamide und sulfonsäure-ester mit je einem trizyclischen heteroring |
| WO1997030038A1 (en) | 1996-02-15 | 1997-08-21 | Mitsubishi Chemical Corporation | Diarylsultam derivatives |
| US6333322B1 (en) | 1996-03-13 | 2001-12-25 | Eisai Co., Ltd. | Nitrogen-containing tricyclic compounds and drugs containing the same |
| EP1057830A4 (en) | 1998-02-27 | 2001-09-19 | Eisai Co Ltd | HETEROCYCLIC CONDENSED BENZOTHIAZINE DERIVATIVES |
| WO2002024657A2 (en) | 2000-09-20 | 2002-03-28 | Schering Corporation | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| AU2003207219A1 (en) | 2002-02-05 | 2003-09-02 | Ajinomoto Co., Inc. | Medicinal compositions containing gabapentin or pregabalin and n-type calcium channel antagonist |
| TW200400816A (en) | 2002-06-26 | 2004-01-16 | Lilly Co Eli | Tricyclic steroid hormone nuclear receptor modulators |
| CN101084209A (zh) | 2004-12-21 | 2007-12-05 | 德福根有限公司 | 具有Kv4离子通道活性的化合物 |
| IT1362675B (it) | 2005-03-15 | 2009-06-25 | Menarini Internat Operations Luxembourg Sa | N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche |
| BRPI0608469A2 (pt) | 2005-04-22 | 2010-01-05 | Alantos Pharmaceuticals Holding Inc | inibidores de dipeptidil peptidase-iv |
| GB0508992D0 (en) | 2005-05-03 | 2005-06-08 | Novartis Ag | Organic compounds |
| CL2007003244A1 (es) | 2006-11-16 | 2008-04-04 | Millennium Pharm Inc | Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. |
| WO2008121859A1 (en) | 2007-03-30 | 2008-10-09 | Xenon Pharmaceuticals Inc. | Methods of using tricyclic compounds in treating sodium channel-mediated diseases or conditions |
| AU2012253759B2 (en) * | 2011-05-06 | 2016-01-21 | Zafgen Inc. | Tricyclic sulfonamide compounds and methods of making and using same |
| HK1198384A1 (en) | 2011-08-16 | 2015-04-17 | Mt. Sinai School Of Medicine | Tricyclic compounds as anticancer agents |
| CA2882826A1 (en) | 2012-08-24 | 2014-02-27 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| CN102942562B (zh) | 2012-12-05 | 2014-10-01 | 天津市斯芬克司药物研发有限公司 | 一种苯并咪唑衍生物及其制备方法和应用 |
| CA2901493A1 (en) | 2013-02-19 | 2014-08-28 | Icahn School Of Medicine At Mount Sinai | Tricyclic heterocycles as anticancer agents |
| CN106458916A (zh) | 2014-03-11 | 2017-02-22 | 西奈山伊坎医学院 | 受限制的三环磺酰胺 |
| JP2017512766A (ja) | 2014-03-11 | 2017-05-25 | アイカーン スクール オブ メディスン アット マウント サイナイＩｃａｈｎ Ｓｃｈｏｏｌ ｏｆ Ｍｅｄｉｃｉｎｅ ａｔ Ｍｔ． Ｓｉｎａｉ | 抗癌剤としてのトリシクリル−２−アミノシクロアルカノール由来スルホンアミド |
| CA2994830A1 (en) | 2015-08-06 | 2017-02-09 | Icahn School Of Medicine At Mount Sinai | Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols |
| WO2017044572A1 (en) | 2015-09-09 | 2017-03-16 | Icahn School Of Medicine At Mount Sinai | Ring constrained diarylamino sulfonamides as anti-cancer agents |
| EP3347350A1 (en) | 2015-09-09 | 2018-07-18 | Icahn School of Medicine at Mount Sinai | Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents |
| WO2017044571A1 (en) | 2015-09-09 | 2017-03-16 | Icahn School Of Medicine At Mount Sinai | Tricyclic sultam sulfonamides as anticancer and neuroprotective agents |
| WO2017044575A1 (en) | 2015-09-09 | 2017-03-16 | Icahn School Of Medicine At Mount Sinai | Constrained benzhydryl sulfonamides as anticancer and neuroprotective agents |
-
2016
- 2016-09-08 JP JP2018512955A patent/JP6955485B2/ja not_active Expired - Fee Related
- 2016-09-08 US US15/758,045 patent/US10759790B2/en active Active
- 2016-09-08 CN CN201680065550.9A patent/CN108349961B/zh not_active Expired - Fee Related
- 2016-09-08 EP EP16766454.9A patent/EP3347355B1/en not_active Not-in-force
- 2016-09-08 WO PCT/US2016/050688 patent/WO2017044569A1/en not_active Ceased
- 2016-09-08 CA CA2997784A patent/CA2997784A1/en not_active Abandoned
- 2016-09-09 AR ARP160102755A patent/AR105975A1/es unknown
- 2016-09-09 TW TW105129416A patent/TW201808930A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018526419A5 (cg-RX-API-DMAC7.html) | ||
| JP2018526416A5 (cg-RX-API-DMAC7.html) | ||
| AU2016216963B2 (en) | Condensed heterocyclic compounds and pesticides | |
| AU2015355839B2 (en) | Heterocyclic derivatives and use thereof | |
| IL278297B2 (en) | Substituted heterocyclic inhibitors of ptpn11 | |
| CN108276352B (zh) | 一种具有杀线虫活性的含氮杂环化合物及其制法和用途 | |
| RU2016142309A (ru) | Пестицидно активные гетероциклические производные с серосодержащими заместителями | |
| JP2015143283A5 (cg-RX-API-DMAC7.html) | ||
| JP2016525075A5 (cg-RX-API-DMAC7.html) | ||
| JP2012528166A5 (cg-RX-API-DMAC7.html) | ||
| WO2012102387A1 (ja) | ピラゾール誘導体及び有害生物防除剤 | |
| PE20190806A1 (es) | Agonistas heterociclicos del receptor de apelina (apj) y usos de los mismos | |
| AR051485A1 (es) | Pirazolo pirimidinas 1,4-sustituidas como inhibidores de quinasa | |
| JP2014524441A5 (cg-RX-API-DMAC7.html) | ||
| JP2014525420A5 (cg-RX-API-DMAC7.html) | ||
| JP2013107867A (ja) | ピラゾール誘導体及び有害生物防除剤 | |
| MX2009010790A (es) | Derivados de heteroarilo biciclico fusionados. | |
| MX2020008570A (es) | Inhibidores de arginasa y sus metodos de uso. | |
| TW200732329A (en) | Aryl-isoxazolo-4-yl-oxadiazole derivatives | |
| EA200970911A1 (ru) | Хинолины и их терапевтическое применение | |
| JP2006523698A5 (cg-RX-API-DMAC7.html) | ||
| CN104530037B (zh) | 一种具有杀线虫活性的三嗪杂环化合物及其制法和用途 | |
| RU2007116987A (ru) | Новые соединения | |
| JP2016508521A5 (cg-RX-API-DMAC7.html) | ||
| JP2018024658A (ja) | 縮合複素環化合物及び有害生物防除剤 |